Tetrahydrofuro [3, 2 -b] pyrrol-3-ones as cathepsin K inhibitors

Details for Australian Patent Application No. 2007274097 (hide)

Owner Armura Therapeutics Limited

Inventors Watts, John Paul; Quibell, Martin

Agent Davies Collison Cave

Pub. Number AU-A-2007274097

PCT Pub. Number WO2008/007114

Priority 0614044.6 14.07.06 GB

Filing date 13 July 2007

Wipo publication date 17 January 2008

International Classifications

C07D 491/04 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

A61K 31/407 (2006.01) - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61P 19/08 (2006.01) Drugs for skeletal disorders

A61P 19/10 (2006.01) Drugs for skeletal disorders

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

5 February 2009 PCT application entered the National Phase

  PCT publication WO2008/007114 Priority application(s): WO2008/007114

30 June 2011 Alteration of Name

  The name of the applicant has been altered to Amura Therapeutics Limited

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007274100-Method of immunisation against the four serotypes of dengue

2007274083-Improvements in and relating to plant protection